:

Homeland Security

Emergent BioSolutions Acquires VaxGen’s Anthrax Vaccine Technology

DDN

Wednesday, May 14th, 2008

SHARE:

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone payments. The arrangement also includes specified percentages of future net sales. VaxGen's original $877 million contract to develop and produce a next-generation anthrax vaccine was terminated by the Department of Health and Human Services in December 2006 due to stability issues with the…

HII Executive Outlines Its Shipbuilding Acceleration Strategy

An HII [HII] shipbuilding executive last week told lawmakers how the company plans to improve and accelerate shipbuilding throughout via workforce improvements, adding new shipbuilding infrastructure and reinforcing distributed shipbuilding […]

Congress

House Sends Dec. 11 CR With Ship Construction Funds To Trump’s Desk For Final Signature

The House on Tuesday passed a stopgap funding bill to keep the government open through Dec. 11, sending the temporary funding measure that also includes funds to support ongoing shipbuilding […]

Missile Defense

Guetlein On Golden Dome: ‘We Cannot Protect This Nation And Bankrupt It At The Same Time’

While there has been criticism among missile defense advocates of Golden Dome’s development pace after the signing of an executive order in January last year, Space Force Gen. Michael Guetlein, […]

Missile Defense

Interview with Rep. Jeff Crank (R-Colo.), co-chair of the Golden Dome Caucus

Rep. Jeff Crank (R-Colo.), a co-chair of the Golden Dome Caucus in Congress and a member of the House Armed Services Committee’s strategic forces panel, discusses the transformative defense investments […]